Sibylla

Trailblazing in Rational Drug Discovery

Keywords

  • Biotech
  • Bootstrap 2017

Industries

Biotech; Drug Discovery

Abstract

At Sibylla Biotech we enjoy scientific challenges and we believe in pursuing original ideas.  This commitment is reflected in our research, which is based on applying innovative algorithms and drug design protocols, derived from advanced mathematical methods of theoretical physics. These new powerful techniques enable us to reveal with atomic resolution the folding and misfolding mechanisms of bio-medically relevant proteins, thereby unveiling an entirely new class of pharmacological targets. Powered by our passion for finding things out, together with our academic and industrial partners, we are opening new paths in rational drug discovery research.

Info

https://www.sibyllabiotech.it/

contact@sibyllabiotech.it

Team

Management

DR. LIDIA PIERI (CEO)

Scientific Advisory Board

PROF. PIETRO FACCIOLI  (Chair)

Group leader in computational biophysics at the Physics Department at the University of Trento (Italy). PI of the BIOPHYS research initiative of the Trento Institute for Pure and Applied Physics (INFN-TIFPA)

PROF. EMILIANO BIASINI

Head of the Dulbecco Telethon Laboratory of Prions & Amyloids at the Center for Integrative Biology (CIBIO) at the University of Trento 

PROF. GRAZIANO LOLLI

Head of the Laboratory of Protein Crystallography and Structure-Based Drug Design at CIBIO at the University of Trento 

PROF. MARIA LETIZIA BARRECA

Head of a research team in computational medicinal chemistry in the Department of Pharmaceutical Science at the University of Perugia (Italy)

GIOVANNI SPAGNOLLI

Doctoral Student in Biotechnology and Quantitative Biology at CIBIO at the University of Trento